Affiliations 

  • 1 Faculty of International Medicine, Department of Biophysics, University of Health Sciences, Istanbul, Turkey
  • 2 Faculty of Medicine, Namık Kemal University, Tekirdağ, Turkey
  • 3 Faculty of Medicine, Yozgat Bozok University, Yozgat, Turkey
  • 4 Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece
  • 5 Neuropharmacology Research Strength, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia
J Neurosci Res, 2022 02;100(2):413-443.
PMID: 34713909 DOI: 10.1002/jnr.24985

Abstract

Epilepsy is a devastating neurological disorder characterized by recurrent seizures attributed to the disruption of the dynamic excitatory and inhibitory balance in the brain. Epilepsy has emerged as a global health concern affecting about 70 million people worldwide. Despite recent advances in pre-clinical and clinical research, its etiopathogenesis remains obscure, and there are still no treatment strategies modifying disease progression. Although the precise molecular mechanisms underlying epileptogenesis have not been clarified yet, the role of ion channels as regulators of cellular excitability has increasingly gained attention. In this regard, emerging evidence highlights the potential implication of inwardly rectifying potassium (Kir) channels in epileptogenesis. Kir channels consist of seven different subfamilies (Kir1-Kir7), and they are highly expressed in both neuronal and glial cells in the central nervous system. These channels control the cell volume and excitability. In this review, we discuss preclinical and clinical evidence on the role of the several subfamilies of Kir channels in epileptogenesis, aiming to shed more light on the pathogenesis of this disorder and pave the way for future novel therapeutic approaches.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.